Literature DB >> 2180244

Naloxone hydrochloride: a review.

P M Goodrich.   

Abstract

Naloxone hydrochloride is a widely used opioid antagonist. Narcotic analgesics administered to patients bind to opioid receptor sites within the central nervous system. Activation of these receptor sites initiates an analgesic response. Blocking of the receptor sites by opioid antagonists, such as naloxone hydrochloride, reverses the effects of the narcotic agonist. Although often used in an emergency room setting in high doses (up to 2 mg), such doses may not be advantageous in an operating room setting where the goal would be the reversal of the respiratory depressant effects of the narcotic while retaining the analgesic properties. Ultimately, the clinician will find that titrating naloxone hydrochloride in small doses (starting as low as .05 mg) will produce the most desirable response.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2180244

Source DB:  PubMed          Journal:  AANA J        ISSN: 0094-6354


  7 in total

1.  No, Mindfulness Meditation-Based Analgesia Is Not Mediated by Endogenous Opioids.

Authors:  Fadel Zeidan
Journal:  Am J Med       Date:  2016-11       Impact factor: 4.965

Review 2.  Opioid antagonists for smoking cessation.

Authors:  Sean P David; Tim Lancaster; Lindsay F Stead; A Eden Evins; Judith J Prochaska
Journal:  Cochrane Database Syst Rev       Date:  2013-06-06

Review 3.  Mechanism of opioid addiction and its intervention therapy: Focusing on the reward circuitry and mu-opioid receptor.

Authors:  Jia-Jia Zhang; Chang-Geng Song; Ji-Min Dai; Ling Li; Xiang-Min Yang; Zhi-Nan Chen
Journal:  MedComm (2020)       Date:  2022-06-22

Review 4.  Systematic review and meta-analysis of opioid antagonists for smoking cessation.

Authors:  Sean P David; Isabella M Chu; Tim Lancaster; Lindsay F Stead; A Eden Evins; Judith J Prochaska
Journal:  BMJ Open       Date:  2014-03-14       Impact factor: 2.692

Review 5.  Historical Review: Opiate Addiction and Opioid Receptors.

Authors:  Shaocheng Wang
Journal:  Cell Transplant       Date:  2018-11-13       Impact factor: 4.064

Review 6.  Opioid Addiction, Genetic Susceptibility, and Medical Treatments: A Review.

Authors:  Shao-Cheng Wang; Yuan-Chuan Chen; Chun-Hung Lee; Ching-Ming Cheng
Journal:  Int J Mol Sci       Date:  2019-09-02       Impact factor: 5.923

7.  Molecular profiling of individual FDA-approved clinical drugs identifies modulators of nonsense-mediated mRNA decay.

Authors:  Jingrong Zhao; Zhelin Li; Ruchira Puri; Kelvin Liu; Israel Nunez; Liang Chen; Sika Zheng
Journal:  Mol Ther Nucleic Acids       Date:  2021-12-10       Impact factor: 8.886

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.